Nyrada Completes Preclinical Studies for Cholesterol-Lowering Program

• All required preclinical safety and toxicology studies have been completed, supporting advancement to a first-in-human clinical trial
• Submission to the Human Research Ethics Committee will be made in July for approval to commence Phase I/IIa study
• Phase I/IIa study on track to start early 2H CY2023